1 Report Overview 1.1 Study Scope 1.2 Market Analysis by Type 1.2.1 Global Genitourinary Drugs Market Size Growth Rate by Type: 2020 VS 2026 1.2.2 Urologicals 1.2.3 Hormonal Therapy 1.2.4 Gynecological 1.2.5 Anti-infectives 1.3 Market by Application 1.3.1 Global Genitourinary Drugs Market Share by Application: 2020 VS 2026 1.3.2 Prostate Cancer 1.3.3 Ovarian Cancer 1.3.4 Bladder Cancer 1.3.5 Cervical Cancer 1.3.6 Renal Cancer 1.3.7 Erectile Dysfunction 1.3.8 Urinary Tract Infections 1.3.9 Urinary Incontinence & Overactive Bladder 1.3.10 Sexually Transmitted Diseases 1.4 Study Objectives 1.5 Years Considered 2 Global Growth Trends 2.1 Global Genitourinary Drugs Market Perspective (2015-2026) 2.2 Global Genitourinary Drugs Growth Trends by Regions 2.2.1 Genitourinary Drugs Market Size by Regions: 2015 VS 2020 VS 2026 2.2.2 Genitourinary Drugs Historic Market Share by Regions (2015-2020) 2.2.3 Genitourinary Drugs Forecasted Market Size by Regions (2021-2026) 2.3 Industry Trends and Growth Strategy 2.3.1 Market Trends 2.3.2 Market Drivers 2.3.3 Market Challenges 2.3.4 Market Restraints 3 Competition Landscape by Key Players 3.1 Global Top Genitourinary Drugs Players by Market Size 3.1.1 Global Top Genitourinary Drugs Players by Revenue (2015-2020) 3.1.2 Global Genitourinary Drugs Revenue Market Share by Players (2015-2020) 3.2 Global Genitourinary Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3) 3.3 Players Covered: Ranking by Genitourinary Drugs Revenue 3.4 Global Genitourinary Drugs Market Concentration Ratio 3.4.1 Global Genitourinary Drugs Market Concentration Ratio (CR5 and HHI) 3.4.2 Global Top 10 and Top 5 Companies by Genitourinary Drugs Revenue in 2019 3.5 Key Players Genitourinary Drugs Area Served 3.6 Key Players Genitourinary Drugs Product Solution and Service 3.7 Date of Enter into Genitourinary Drugs Market 3.8 Mergers & Acquisitions, Expansion Plans 4 Genitourinary Drugs Breakdown Data by Type (2015-2026) 4.1 Global Genitourinary Drugs Historic Market Size by Type (2015-2020) 4.2 Global Genitourinary Drugs Forecasted Market Size by Type (2021-2026) 5 Genitourinary Drugs Breakdown Data by Application (2015-2026) 5.1 Global Genitourinary Drugs Historic Market Size by Application (2015-2020) 5.2 Global Genitourinary Drugs Forecasted Market Size by Application (2021-2026) 6 North America 6.1 North America Genitourinary Drugs Market Size (2015-2026) 6.2 North America Genitourinary Drugs Market Size by Type (2015-2020) 6.3 North America Genitourinary Drugs Market Size by Application (2015-2020) 6.4 North America Genitourinary Drugs Market Size by Country (2015-2020) 6.4.1 United States 6.4.2 Canada 7 Europe 7.1 Europe Genitourinary Drugs Market Size (2015-2026) 7.2 Europe Genitourinary Drugs Market Size by Type (2015-2020) 7.3 Europe Genitourinary Drugs Market Size by Application (2015-2020) 7.4 Europe Genitourinary Drugs Market Size by Country (2015-2020) 7.4.1 Germany 7.4.2 France 7.4.3 U.K. 7.4.4 Italy 7.4.5 Russia 7.4.6 Nordic 7.4.7 Rest of Europe 8 China 8.1 China Genitourinary Drugs Market Size (2015-2026) 8.2 China Genitourinary Drugs Market Size by Type (2015-2020) 8.3 China Genitourinary Drugs Market Size by Application (2015-2020) 8.4 China Genitourinary Drugs Market Size by Region (2015-2020) 8.4.1 China 8.4.2 Japan 8.4.3 South Korea 8.4.4 Southeast Asia 8.4.5 India 8.4.6 Australia 8.4.7 Rest of Asia-Pacific 9 Japan 9.1 Japan Genitourinary Drugs Market Size (2015-2026) 9.2 Japan Genitourinary Drugs Market Size by Type (2015-2020) 9.3 Japan Genitourinary Drugs Market Size by Application (2015-2020) 9.4 Japan Genitourinary Drugs Market Size by Country (2015-2020) 9.4.1 Mexico 9.4.2 Brazil 10 Southeast Asia 10.1 Southeast Asia Genitourinary Drugs Market Size (2015-2026) 10.2 Southeast Asia Genitourinary Drugs Market Size by Type (2015-2020) 10.3 Southeast Asia Genitourinary Drugs Market Size by Application (2015-2020) 10.4 Southeast Asia Genitourinary Drugs Market Size by Country (2015-2020) 10.4.1 Turkey 10.4.2 Saudi Arabia 10.4.3 UAE 10.4.4 Rest of Middle East & Africa 11 Key Players Profiles 11.1 Novartis AG 11.1.1 Novartis AG Company Details 11.1.2 Novartis AG Business Overview 11.1.3 Novartis AG Genitourinary Drugs Introduction 11.1.4 Novartis AG Revenue in Genitourinary Drugs Business (2015-2020)) 11.1.5 Novartis AG Recent Development 11.2 Genentech 11.2.1 Genentech Company Details 11.2.2 Genentech Business Overview 11.2.3 Genentech Genitourinary Drugs Introduction 11.2.4 Genentech Revenue in Genitourinary Drugs Business (2015-2020) 11.2.5 Genentech Recent Development 12 Analyst's Viewpoints/Conclusions 13 Appendix 13.1 Research Methodology 13.1.1 Methodology/Research Approach 13.1.2 Data Source 13.2 Disclaimer 13.3 Author Details

List of Tables Table 1. Global Genitourinary Drugs Market Size Growth Rate by Type (US$ Million): 2020 VS 2026 Table 3. Key Players of Urologicals Table 4. Key Players of Hormonal Therapy Table 5. Key Players of Gynecological Table 6. Key Players of Anti-infectives Table 7. Global Genitourinary Drugs Market Size Growth by Application (US$ Million): 2020 VS 2026 Table 8. Global Genitourinary Drugs Market Size by Regions (US$ Million): 2020 VS 2026 Table 9. Global Genitourinary Drugs Market Size by Regions (2015-2020) (US$ Million) Table 10. Global Genitourinary Drugs Market Share by Regions (2015-2020) Table 11. Global Genitourinary Drugs Forecasted Market Size by Regions (2021-2026) (US$ Million) Table 12. Global Genitourinary Drugs Market Share by Regions (2021-2026) Table 13. Genitourinary Drugs Market Market Trends Table 14. Genitourinary Drugs Market Drivers Table 15. Genitourinary Drugs Market Challenges Table 16. Genitourinary Drugs Market Restraints Table 17. Global Genitourinary Drugs Revenue by Players (2015-2020) (US$ Million) Table 18. Global Genitourinary Drugs Market Share by Players (2015-2020) Table 19. Global Top Genitourinary Drugs Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Genitourinary Drugs as of 2019) Table 20. Global Genitourinary Drugs by Players Market Concentration Ratio (CR5 and HHI) Table 21. Key Players Headquarters and Area Served Table 22. Key Players Genitourinary Drugs Product Solution and Service Table 23. Mergers & Acquisitions, Expansion Plans Table 24. Global Genitourinary Drugs Market Size by Type (2015-2020) (US$ Million) Table 25. Global Genitourinary Drugs Market Size Share by Type (2015-2020) Table 26. Global Genitourinary Drugs Revenue Market Share by Type (2021-2026) Table 27. Global Genitourinary Drugs Market Size Share by Application (2015-2020) Table 28. Global Genitourinary Drugs Market Size by Application (2015-2020) (US$ Million) Table 29. Global Genitourinary Drugs Market Size Share by Application (2021-2026) Table 30. North America Genitourinary Drugs Market Size by Type (2015-2020) (US$ Million) Table 31. North America Genitourinary Drugs Market Share by Type (2015-2020) Table 32. North America Genitourinary Drugs Market Size by Application (2015-2020) (US$ Million) Table 33. North America Genitourinary Drugs Market Share by Application (2015-2020) Table 34. North America Genitourinary Drugs Market Size by Country (US$ Million) (2015-2020) Table 35. North America Genitourinary Drugs Market Share by Country (2015-2020) Table 36. Europe Genitourinary Drugs Market Size by Type (2015-2020) (US$ Million) Table 37. Europe Genitourinary Drugs Market Share by Type (2015-2020) Table 38. Europe Genitourinary Drugs Market Size by Application (2015-2020) (US$ Million) Table 39. Europe Genitourinary Drugs Market Share by Application (2015-2020) Table 40. Europe Genitourinary Drugs Market Size by Country (US$ Million) (2015-2020) Table 41. Europe Genitourinary Drugs Market Share by Country (2015-2020) Table 42. China Genitourinary Drugs Market Size by Type (2015-2020) (US$ Million) Table 43. China Genitourinary Drugs Market Share by Type (2015-2020) Table 44. China Genitourinary Drugs Market Size by Application (2015-2020) (US$ Million) Table 45. China Genitourinary Drugs Market Share by Application (2015-2020) Table 46. China Genitourinary Drugs Market Size by Region (US$ Million) (2015-2020) Table 47. China Genitourinary Drugs Market Share by Region (2015-2020) Table 48. Japan Genitourinary Drugs Market Size by Type (2015-2020) (US$ Million) Table 49. Japan Genitourinary Drugs Market Share by Type (2015-2020) Table 50. Japan Genitourinary Drugs Market Size by Application (2015-2020) (US$ Million) Table 51. Japan Genitourinary Drugs Market Share by Application (2015-2020) Table 52. Japan Genitourinary Drugs Market Size by Country (US$ Million) (2015-2020) Table 53. Japan Genitourinary Drugs Market Share by Country (2015-2020) Table 54. Southeast Asia Genitourinary Drugs Market Size by Type (2015-2020) (US$ Million) Table 55. Southeast Asia Genitourinary Drugs Market Share by Type (2015-2020) Table 56. Southeast Asia Genitourinary Drugs Market Size by Application (2015-2020) (US$ Million) Table 57. Southeast Asia Genitourinary Drugs Market Share by Application (2015-2020) Table 58. Southeast Asia Genitourinary Drugs Market Size by Country (US$ Million) (2015-2020) Table 59. Southeast Asia Genitourinary Drugs Market Share by Country (2015-2020) Table 60. Novartis AG Company Details Table 61. Novartis AG Business Overview Table 62. Novartis AG Product Table 63. Novartis AG Revenue in Genitourinary Drugs Business (2015-2020) (US$ Million) Table 64. Novartis AG Recent Development Table 65. Genentech Company Details Table 66. Genentech Business Overview Table 67. Genentech Product Table 68. Genentech Revenue in Genitourinary Drugs Business (2015-2020) (US$ Million) Table 69. Genentech Recent Development Table 70. Research Programs/Design for This Report Table 71. Key Data Information from Secondary Sources Table 72. Key Data Information from Primary Sources List of Figures Figure 1. Global Genitourinary Drugs Market Share by Type: 2020 VS 2026 Figure 2. Urologicals Features Figure 3. Hormonal Therapy Features Figure 4. Gynecological Features Figure 5. Anti-infectives Features Figure 6. Global Genitourinary Drugs Market Share by Application: 2020 VS 2026 Figure 7. Prostate Cancer Case Studies Figure 8. Ovarian Cancer Case Studies Figure 9. Bladder Cancer Case Studies Figure 10. Cervical Cancer Case Studies Figure 11. Renal Cancer Case Studies Figure 12. Erectile Dysfunction Case Studies Figure 13. Urinary Tract Infections Case Studies Figure 14. Urinary Incontinence & Overactive Bladder Case Studies Figure 15. Sexually Transmitted Diseases Case Studies Figure 16. Genitourinary Drugs Report Years Considered Figure 17. Global Genitourinary Drugs Market Size (US$ Million), YoY Growth 2015-2026 Figure 18. Global Genitourinary Drugs Market Share by Regions: 2020 VS 2026 Figure 19. Global Genitourinary Drugs Market Share by Regions (2021-2026) Figure 20. Global Genitourinary Drugs Market Share by Players in 2019 Figure 21. Global Top Genitourinary Drugs Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Genitourinary Drugs as of 2019 Figure 22. The Top 10 and 5 Players Market Share by Genitourinary Drugs Revenue in 2019 Figure 23. North America Genitourinary Drugs Market Size YoY Growth (2015-2026) & (US$ Million) Figure 24. United States Genitourinary Drugs Market Size YoY Growth (2015-2026) & (US$ Million) Figure 25. Canada Genitourinary Drugs Market Size YoY Growth (2015-2026) & (US$ Million) Figure 26. Europe Genitourinary Drugs Market Size YoY Growth (2015-2026) & (US$ Million) Figure 27. Germany Genitourinary Drugs Market Size YoY Growth (2015-2026) & (US$ Million) Figure 28. France Genitourinary Drugs Market Size YoY Growth (2015-2026) & (US$ Million) Figure 29. U.K. Genitourinary Drugs Market Size YoY Growth (2015-2026) & (US$ Million) Figure 30. Italy Genitourinary Drugs Market Size YoY Growth (2015-2026) & (US$ Million) Figure 31. Russia Genitourinary Drugs Market Size YoY Growth (2015-2026) & (US$ Million) Figure 32. Nordic Genitourinary Drugs Market Size YoY Growth (2015-2026) & (US$ Million) Figure 33. Rest of Europe Genitourinary Drugs Market Size YoY Growth (2015-2026) & (US$ Million) Figure 34. Asia-Pacific Genitourinary Drugs Market Size YoY Growth (2015-2026) & (US$ Million) Figure 35. China Genitourinary Drugs Market Size YoY Growth (2015-2026) & (US$ Million) Figure 36. Japan Genitourinary Drugs Market Size YoY Growth (2015-2026) & (US$ Million) Figure 37. South Korea Genitourinary Drugs Market Size YoY Growth (2015-2026) & (US$ Million) Figure 38. Southeast Asia Genitourinary Drugs Market Size YoY Growth (2015-2026) & (US$ Million) Figure 39. India Genitourinary Drugs Market Size YoY Growth (2015-2026) & (US$ Million) Figure 40. Australia Genitourinary Drugs Market Size YoY Growth (2015-2026) & (US$ Million) Figure 41. Rest of Asia-Pacific Genitourinary Drugs Market Size YoY Growth (2015-2026) & (US$ Million) Figure 42. Latin America Genitourinary Drugs Market Size YoY Growth (2015-2026) & (US$ Million) Figure 43. Mexico Genitourinary Drugs Market Size YoY Growth (2015-2026) & (US$ Million) Figure 44. Brazil Genitourinary Drugs Market Size YoY Growth (2015-2026) & (US$ Million) Figure 45. Middle East & Africa Genitourinary Drugs Market Size YoY Growth (2015-2026) & (US$ Million) Figure 46. Turkey Genitourinary Drugs Market Size YoY Growth (2015-2026) & (US$ Million) Figure 47. Saudi Arabia Genitourinary Drugs Market Size YoY Growth (2015-2026) & (US$ Million) Figure 48. UAE Genitourinary Drugs Market Size YoY Growth (2015-2026) & (US$ Million) Figure 49. Rest of Middle East & Africa Genitourinary Drugs Market Size YoY Growth (2015-2026) & (US$ Million) Figure 50. Novartis AG Revenue Growth Rate in Genitourinary Drugs Business (2015-2020) Figure 51. Genentech Revenue Growth Rate in Genitourinary Drugs Business (2015-2020) Figure 52. Bottom-up and Top-down Approaches for This Report Figure 53. Data Triangulation Figure 54. Key Executives Interviewed

Novartis AG Genentech